INNOBIOSCIENCE LLC
BRADENTON, FLORIDA

InnoBioscience LLC, based in Bradenton, Florida, was founded on July 17, 2013, as a clinical-stage biopharmaceutical company. Their mission is to develop cutting-edge therapies for complex conditions like autoimmune diseases, Multiple Sclerosis, Rheumatoid Arthritis, Alzheimer's Disease, Fibrosis, and Duchene Muscular Dystrophy. By focusing on innovative inhalation delivery systems, they aim to fill the gaps in current medical treatments. InnoBioscience collaborates closely with leading scientists to streamline research efforts, reducing costs while maintaining high standards of development. This strategic partnership not only accelerates progress but also aids in securing necessary government funding for their projects. A team of renowned researchers and clinical experts forms the backbone of InnoBioscience, bringing invaluable expertise in both autoimmune disease treatment and specialized delivery methods. The company's operations are efficiently managed under the classification FloridaModels.Dos.FloridaCompanyStatus and hold an official filing number L13000101833. They're located at 707 24th Ave West, Bradenton, FL, and can be reached via phone at (866) 363-3082; (941) 827-1136; or (866) 278-2874. Under the leadership of Manager Annie Eng, InnoBioscience continues to prioritize innovation and patient outcomes. As expressed in their latest annual report update from February 1, 2024, they remain dedicated to advancing research that addresses some of today's most pressing medical challenges.